Carrito 0

No hay más productos disponibles para comprar

Productos
Combinar con
¿Esto es un regalo?
Continue Shopping
Subtotal Gratis
Los gastos del envío, los impuestos y los códigos de descuento se calculan al finalizar la compra

The Bardo Foundation 2025 Annual Report

The Bardo Foundation 2025 Annual Report

We are proud to share our 2025 Annual Report, a celebration of impact, progress, and the collective effort driving change for children and families affected by osteosarcoma.

2025 was a year defined by connection and meaningful steps forward, all made possible because of you, our community of supporters standing together with us.

Throughout the year, our focus has remained clear, to fund vital research, support families, and build a global community committed to improving outcomes for young people facing this rare and aggressive cancer. This Annual Report captures what has been possible through shared belief, determination, and generosity.

Key Highlights from 2025

2025 marked several important milestones for The Bardo Foundation in our fight against osteosarcoma. We became a founding partner in Break Through Cancer’s Defying Osteosarcoma TeamLab, a radical research project not previously seen in the osteosarcoma community, supported the publication of our first scientific paper arising from foundation funded research, achieved UK charity registration, and welcomed our first full time staff member. Each of these steps strengthens our ability to fund research, build partnerships, and support families more effectively.

Where Your Support Made a Difference

Our Annual Report shows how funds raised were invested across research, community initiatives, and patient support. Behind every figure is a story of compassion turned into action. From supporting international research collaborations to expanding our events and fundraising programmes, your support has driven real impact.

Thank You

To every supporter who gave through donations, time, or shared expertise, this Annual Report belongs to all of you. We invite you to read it, share it, and help us carry its momentum forward as we continue working toward better treatments, better outcomes, and brighter futures.

 

Deja un comentario

Ten en cuenta que los comentarios deben ser aprobados antes de su publicación.